Bruce Bostrom

8.3k total citations
129 papers, 6.0k citations indexed

About

Bruce Bostrom is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Bruce Bostrom has authored 129 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Public Health, Environmental and Occupational Health, 47 papers in Pediatrics, Perinatology and Child Health and 47 papers in Hematology. Recurrent topics in Bruce Bostrom's work include Acute Lymphoblastic Leukemia research (76 papers), Childhood Cancer Survivors' Quality of Life (42 papers) and Acute Myeloid Leukemia Research (28 papers). Bruce Bostrom is often cited by papers focused on Acute Lymphoblastic Leukemia research (76 papers), Childhood Cancer Survivors' Quality of Life (42 papers) and Acute Myeloid Leukemia Research (28 papers). Bruce Bostrom collaborates with scholars based in United States, Switzerland and Australia. Bruce Bostrom's co-authors include Paul S. Gaynon, James B. Nachman, Gary R. Erdmann, Harland N. Sather, Raymond J. Hutchinson, Peter G. Steinherz, Fatih M. Uckun, Beverly J. Lange, Nyla A. Heerema and Susan Sencer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Bruce Bostrom

126 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Bostrom United States 44 2.9k 2.1k 1.9k 1.2k 1.1k 129 6.0k
Howard J. Weinstein United States 43 1.6k 0.6× 2.2k 1.0× 736 0.4× 850 0.7× 1.2k 1.1× 122 5.4k
Peter F. Coccia United States 44 1.7k 0.6× 1.7k 0.8× 1.1k 0.6× 1.3k 1.1× 1.5k 1.4× 108 5.7k
Ajay Vora United Kingdom 44 4.5k 1.5× 3.3k 1.5× 2.8k 1.5× 887 0.8× 1.3k 1.2× 184 6.7k
James H. Feusner United States 39 1.4k 0.5× 2.5k 1.2× 954 0.5× 2.7k 2.4× 1.3k 1.2× 149 6.1k
Kirk R. Schultz Canada 45 2.6k 0.9× 5.0k 2.3× 1.2k 0.7× 770 0.7× 1.3k 1.2× 214 7.4k
Michael A. Pulsipher United States 47 2.1k 0.7× 4.5k 2.1× 1.2k 0.6× 1.1k 1.0× 2.4k 2.2× 253 7.6k
Alan S. Gamis United States 41 1.7k 0.6× 3.1k 1.5× 696 0.4× 1.6k 1.4× 1.1k 1.0× 222 5.0k
Joseph Mirro United States 35 2.0k 0.7× 2.7k 1.3× 497 0.3× 1.2k 1.1× 822 0.8× 93 4.7k
Valentino Conter Italy 36 2.6k 0.9× 1.7k 0.8× 1.8k 0.9× 608 0.5× 760 0.7× 154 4.0k
Ursula Creutzig Germany 53 3.0k 1.0× 5.2k 2.4× 812 0.4× 2.5k 2.2× 1.8k 1.6× 217 7.6k

Countries citing papers authored by Bruce Bostrom

Since Specialization
Citations

This map shows the geographic impact of Bruce Bostrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Bostrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Bostrom more than expected).

Fields of papers citing papers by Bruce Bostrom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Bostrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Bostrom. The network helps show where Bruce Bostrom may publish in the future.

Co-authorship network of co-authors of Bruce Bostrom

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Bostrom. A scholar is included among the top collaborators of Bruce Bostrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Bostrom. Bruce Bostrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roby, Brianne Barnett, et al.. (2019). Vincristine-induced vocal cord paresis and paralysis in children. International Journal of Pediatric Otorhinolaryngology. 123. 1–4. 11 indexed citations
2.
Bostrom, Bruce, et al.. (2019). Methotrexate Polyglutamate Values in Children and Adolescents With Acute Lymphoblastic Leukemia During Maintenance Therapy. Journal of Pediatric Hematology/Oncology. 41(6). 429–432. 5 indexed citations
3.
Tanner, Lynn, et al.. (2019). Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 41(6). 457–462. 3 indexed citations
4.
Beaupin, Lynda K., et al.. (2016). Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review. Leukemia & lymphoma. 58(4). 766–772. 11 indexed citations
5.
Bhatia, Ravi, Wendy Landier, Lindsey Hageman, et al.. (2014). 6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 124(15). 2345–2353. 152 indexed citations
6.
Raetz, Elizabeth A., D. Morrison, Paul S. Gaynon, et al.. (2013). A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL). Journal of Pediatric Hematology/Oncology. 36(6). 458–463. 34 indexed citations
7.
Messinger, Yoav H., Paul S. Gaynon, Richard Sposto, et al.. (2012). Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study. Blood. 120(2). 285–290. 150 indexed citations
8.
Kadan‐Lottick, Nina S., Pim Brouwers, David Breiger, et al.. (2009). Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 27(35). 5986–5992. 54 indexed citations
9.
10.
Tolar, Jakub, Bruce Bostrom, Mei La, & Harland N. Sather. (2004). Intravenous 6‐mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group study CCG 1922. Pediatric Blood & Cancer. 45(1). 5–9. 5 indexed citations
11.
Bostrom, Bruce, et al.. (2003). Plasma pharmacokinetics of high‐dose oral busulfan in children and adults undergoing bone marrow transplantation. Pediatric Transplantation. 7(s3). 12–18. 31 indexed citations
12.
13.
Heerema, Nyla A., Harland N. Sather, Raymond J. Hutchinson, et al.. (2000). Clinical Significance of Deletions of Chromosome Arm 6q in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Cancer Group. Leukemia & lymphoma. 36(5-6). 467–478. 25 indexed citations
14.
Uckun, Fatih M., Barbara Waurzyniak, Harland N. Sather, et al.. (1999). Prognostic Significance of T-Lineage Leukemic Cell Growth in SCID Mice: A Children's Cancer Group Study. Leukemia & lymphoma. 32(5-6). 475–487. 13 indexed citations
15.
Bostrom, Bruce, Marion A. Koerper, Maura O’Leary, et al.. (1997). One Course Versus Two Courses of Antithymocyte Globulin for the Treatment of Severe Aplastic Anemia in Children. ˜The œAmerican journal of pediatric hematology/oncology. 19(2). 110–114. 12 indexed citations
16.
Gaynon, Paul S., Harland N. Sather, Bruce Bostrom, et al.. (1997). Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 Fusion Transcripts in Newly Diagnosed Children with Acute Lymphoblastic Leukemia: A Children's Cancer Group Initiative. Leukemia & lymphoma. 26(1-2). 57–65. 22 indexed citations
17.
Finlay, Jonathan L., Stewart Goldman, Mitchell S. Cairo, et al.. (1996). Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.. Journal of Clinical Oncology. 14(9). 2495–2503. 152 indexed citations
18.
Erdmann, Gary R., et al.. (1991). Reversed-phase high-performance liquid chromatographic approach to determine total lymphocyte concentrations of 6-thioguanine, methylmercaptopurine and methylthioguanine in humans. Journal of Chromatography B Biomedical Sciences and Applications. 571(1-2). 149–156. 20 indexed citations
19.
Kim, Tae Hyong, Philip B. McGlave, Norma K.C. Ramsay, et al.. (1990). Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. International Journal of Radiation Oncology*Biology*Physics. 19(4). 889–897. 43 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard J. Weinstein Breakdown of academic impact, for papers by Peter F. Coccia Breakdown of academic impact, for papers by Ajay Vora Breakdown of academic impact, for papers by James H. Feusner Breakdown of academic impact, for papers by Kirk R. Schultz Breakdown of academic impact, for papers by Michael A. Pulsipher Breakdown of academic impact, for papers by Alan S. Gamis Breakdown of academic impact, for papers by Joseph Mirro Breakdown of academic impact, for papers by Valentino Conter Breakdown of academic impact, for papers by Ursula Creutzig
Rankless by CCL
2026